Opthea (OPT) Announces Executive Changes

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. ANT
3. SPY
4. META
5. FFAI
6. FFR
7. AZN
8. CART
9. LLY
10. TSLA

Go back to Opthea (OPT) Announces Executive Changes

Opthea Announces Executive Leadership Changes and Senior Hires

September 5, 2024 6:00 AM EDT

Daniel Geffken appointed Chief Financial Officer ad interim

Mike Campbell appointed Chief Commercial Officer

Three senior leaders appointed for Biometrics, Clinical Operations and Market Access

MELBOURNE, Australia and PRINCETON, N.J., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT, Opthea, the Company), a clinical-stage biopharmaceutical Company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced executive leadership changes in Commercial and Finance as well as senior hires for Biometrics, Clinical Operations and Market... More